Please login to the form below

Not currently logged in
Email:
Password:

Marathon Pharma

This page shows the latest Marathon Pharma news and features for those working in and with pharma, biotech and healthcare.

Marathon pauses Emflaza launch amid pricing furore

Marathon pauses Emflaza launch amid pricing furore

Marathon pauses Emflaza launch amid pricing furore. US Senator Bernie Sanders calls Duchenne muscular dystrophy drug’ s pricing “ unconscionable”. ... In response, Marathon has said it is "pausing its commercialisation plans" for Emflaza while it

Latest news

  • FDA approves first steroid for Duchenne muscular dystrophy FDA approves first steroid for Duchenne muscular dystrophy

    FDA approves first steroid for Duchenne muscular dystrophy. Marathon Pharma’ s Emflaza is first approved to treat all genetic forms of the condition. ... The FDA has cleared a second drug for Duchenne muscular dystrophy, giving the green light to

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • A marathon and a sprint A marathon and a sprint

    A marathon and a sprint. Customer experience is a long-distance race and with pharma late out of the blocks, companies need to put their foot down if they want to ... Pharma’s CX marathon involves multiple participants; prescribers, policy-makers,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics